The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Chemotherapy-based stem cell mobilization in multiple myeloma patients treated with novel agents: The Mayo Clinic experience.
 
Iuliana Vaxman
No Relationships to Disclose
 
Eli Muchtar
No Relationships to Disclose
 
Prashant Kapoor
Honoraria - BeiGene; Cellectar; Clinical Care Options; GlaxoSmithKline (Inst); Karyopharm Therapeutics; Pharmacyclics; Sanofi (Inst)
Consulting or Advisory Role - Sanofi (Inst)
Research Funding - Abbvie (Inst); Amgen (Inst); GlaxoSmithKline (Inst); Karyopharm Therapeutics (Inst); Regeneron (Inst); Sanofi (Inst); Sorrento Therapeutics (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Janssen; Sanofi
 
Shaji Kumar
Consulting or Advisory Role - Abbvie (Inst); Abbvie (Inst); Amgen (Inst); Bluebird Bio (Inst); Celgene (Inst); Cellectar; Genecentrix; Genentech/Roche (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); Merck (Inst); Molecular Partners (Inst); Oncopeptides; Takeda (Inst)
Research Funding - Abbvie (Inst); CARsgen Therapeutics (Inst); Celgene (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst); Sanofi (Inst); Takeda (Inst); TeneoBio (Inst)
 
Angela Dispenzieri
Consulting or Advisory Role - Janssen Research & Development
Research Funding - Alnylam (Inst); Celgene (Inst); Janssen Oncology (Inst); Pfizer (Inst); Prothena; Takeda (Inst)
Travel, Accommodations, Expenses - Janssen Oncology; Pfizer; Prothena
 
Francis Buadi
No Relationships to Disclose
 
David Dingli
No Relationships to Disclose
 
Wilson I. Gonsalves
No Relationships to Disclose
 
Taxiarchis Kourelis
No Relationships to Disclose
 
Rahma M. Warsame
No Relationships to Disclose
 
Martha Lacy
No Relationships to Disclose
 
William J. Hogan
No Relationships to Disclose
 
Morie A. Gertz
Stock and Other Ownership Interests - Aurora Biopharma
Honoraria - Abbvie; Akcea Therapeutics; Ambry Genetics; Amgen; Celgene; Celgene; Janssen; Karyopharm Therapeutics; Pfizer (Inst); Research to Practice; Sanofi
Consulting or Advisory Role - Akcea Therapeutics; Alnylam; Ionis Pharmaceuticals; Prothena